Cardwell, Chris RMcDowell, Ronald DHughes, Carmel MBusby, JohnMurchie, Peter2024-10-082024-10-082024-06Cardwell, C R, McDowell, R D, Hughes, C M, Busby, J & Murchie, P 2024, 'Oral prednisolone and warfarin and risk of oesophageal cancer : A case-control study', Cancer Epidemiology, vol. 90, 102552. https://doi.org/10.1016/j.canep.2024.1025521877-7821ORCID: /0000-0001-9968-5991/work/169538588https://hdl.handle.net/2164/24362Acknowledgements: This work was supported by Cancer Research UK (reference C37316/A25535). The sponsors had no involvement with the planning, execution, or completion of the study. This study is based in part on data from the Clinical Practice Research Datalink obtained under licence from the UK Medicines and Healthcare products Regulatory Agency. The data is provided by patients and collected by the NHS as part of their care and support. The National Cancer Registration Dataset Copyright © (2020) was re-used with the permission of The Health & Social Care Information Centre. All rights reserved. The interpretation and conclusions contained in this study are those of the author/s alone.7408443engSDG 3 - Good Health and Well-beingCorticosteroidsOesophageal cancerEpidemiologyPrednisoloneWarfarinR MedicineCancer Research UKC37316/A25535RJournal article10.1016/j.canep.2024.10255290